Tag: Collaboration

Start-Up and BHF Launched Ecard Collaboration

cooperation handshake
A disruptive young start-up has launched a charity collaboration to make a Christmas card that reminds people of the work the British Heart Foundation (BHF) does to keep families together at Christmas...

Acceleron Announced Research and Discovery Collaboration Agreement with Fulcrum Therapeutics

research
Acceleron Pharma has entered into a pulmonary research and discovery collaboration agreement with Fulcrum Therapeutics. As part of the collaboration and license agreement, the companies will wo...

UVA Center for Diabetes Technology and Novo Nordisk Entered Five-Year Research Collaboration

novo nordisk
University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on t...

Arcus Biosciences Announced Clinical Collaboration with Genentech

Arcus Biosciences, Inc., an oncology-focused biopharmaceutical company discovering and developing highly-differentiated therapies, announced a clinical collaboration with Genentech, a member of the Ro...

BioArctic AB Announced Research Collaboration with Eisai

BioArctic AB announced the initiation of a research collaboration with Eisai aimed at further studying the unique profile of the investigational drug candidate BAN2401. The research collaboration w...

AbbVie and Scripps Research Announce Collaboration to Develop New Therapies

AbbVie and Scripps Research announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology and fibrosis. "Based on o...

Forendo Pharma Signed License and Collaboration Agreement with Novartis

novartis
Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, announced the signing of a License and Collaboration Agreement with Novartis. The joint resear...

Bioncotech Entered Clinical Trial Collaboration with Merck

merck-kgaa
Bioncotech Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces it has entered into a Phase II clinical trial collaboration with a subsidia...

Samyang Biopharm USA Entered into Research Collaboration with Talix Therapeutics NV

r&d
Samyang Biopharm USA, Inc., a global biotech subsidiary of the Samyang Pharmaceuticals Corp., announced that the company has entered into a research collaboration with the exclusive option to a worldw...

AbbVie Announced Collaboration with Scripps Research to Develop New Therapies

AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration to develop new t...

RAPT and Hanmi Agreed to Collaborate on FLX475 Licencing and Commercialisation in Asia

US immune-oncology drug developer RAPT Therapeutics and South Korea’s Hanmi Pharmaceutical have entered into a license and collaboration agreement for FLX475 in Asia, worth up to $118 million, with th...

Mission Therapeutics and AbbVie to Collaborate in AD and PD Study

alzheimer's disease
Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), and AbbVie, a global, research-driven biopharmaceutical company, annou...

RAPT and Hanmi Announced License and Collaboration Agreement for FLX475 in Asia

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant ...

Seattle Genetic and Astellas Pharma Announced Clinical Collaboration Agreement with Merck

Merck
Seattle Genetics, Inc. and Astellas Pharma Inc., announced a clinical collaboration agreement with Merck, known as MSD outside the United States and Canada through a subsidiary, to evaluate the combin...

Lonza and DiNAQOR AG Announced Strategic Collaboration to Advance DiNAQOR’s Preclinical Progra...

Lonza and DiNAQOR AG, a global gene therapy platform company, announced a strategic collaboration to advance DiNAQOR's preclinical programs for the treatment of cardiac myosin-binding protein-C (MYBPC...

Teva and Weizmann Institute of Science to Identify Innovative Antibodies for Cancer Treatment

adc
Teva and Yeda Research and Development Company, the Weizmann Institute of Science’s commercial arm, signed a unique collaboration agreement that includes financial support and collaborative efforts by...